Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Tiger-3: A Phase 3 Randomized Study of Rociletinib Vs Chemotherapy in EGFR-mutated Non-small Cell Lung Cancer (NSCLC) Yang, J. C., Reckamp, K., Kim, Y., Novello, S., Smit, E., Lee, J., Su, W., Akerley, W., Blakely, C., Bazhenova, L., Chiari, R., Hsia, T., Golsorkhi, T., Despain, D., Shih, D., Rolfe, L., Popat, S., Wakelee, H. ELSEVIER SCIENCE INC. 2017: S2397
View details for DOI 10.1016/j.jtho.2017.11.013
View details for Web of Science ID 000463860802549